Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sangamo Therapeutics Ownership Summary


Sangamo Therapeutics is owned by 19.94% institutional investors, 2.16% insiders, and 77.90% retail investors. Vanguard group is the largest institutional shareholder, holding 4.50% of SGMO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.51% of its assets in Sangamo Therapeutics shares.

SGMO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSangamo Therapeutics19.94%2.16%77.90%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group9.37M4.50%$9.56M
Wasatch advisors lp8.08M3.15%$4.38M
Blackrock4.70M2.61%$1.69M
Blackrock funding, inc. /de4.81M1.87%$2.60M
Jacobs levy equity management2.95M1.64%$1.06M
Renaissance3.08M1.48%$3.15M
Millennium management2.74M1.31%$2.79M
Geode capital management2.21M1.06%$2.26M
Goldman sachs group1.61M0.77%$1.64M
Northern trust1.20M0.67%$430.33K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital1.26M0.13%$682.13K
Golden state equity partners391.94K0.04%$212.16K
Sanders morris harris188.50K0.02%$102.03K
Wasatch advisors lp8.08M0.02%$4.38M
Lji wealth management24.26K0.00%$24.75K
Renaissance3.08M0.00%$3.15M
Founders capital management14.00K0.00%$7.58K
Jacobs levy equity management2.95M0.00%$1.06M
Sandbox financial partners24.83K0.00%$13.44K
Boothbay fund management318.82K0.00%$172.58K

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management2.95M0.00%2.76M
Goldman sachs group1.61M0.00%1.54M
Wasatch advisors lp8.08M0.02%1.22M
Millennium management2.74M0.00%828.34K
Squarepoint ops710.36K0.00%710.36K

Top Sellers

HolderShares% AssetsChange
Armistice capital---14.06M
Blackrock4.70M--8.57M
Acadian asset management---4.56M
State street519.22K--2.23M
Point72 asset management---2.00M

New Positions

HolderShares% AssetsChangeValue
Squarepoint ops710.36K0.00%710.36K$724.57K
Sanders morris harris188.50K0.02%188.50K$102.03K
Mariner60.78K-60.78K$32.90K
Private advisor group28.00K0.00%28.00K$15.16K
Physician wealth advisors1.27K0.00%1.27K$688.00

Sold Out

HolderChange
Headlands-5.00
Td waterhouse canada-31.00
Gps wealth strategies group-100.00
Srs capital advisors-142.00
Kohmann bosshard financial services-155.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025118-9.92%51,227,326-2.55%193.50%47-16.07%32-5.88%
Mar 31, 2025130-4.41%52,338,132-14.91%232.73%55-22.54%349.68%
Dec 31, 202413218.92%56,338,8180.73%273.75%6763.41%31-6.06%
Sep 30, 2024111-13.28%55,928,091-35.58%261.16%41-28.07%33-23.26%
Jun 30, 2024128-3.03%86,818,721-14.00%481.54%577.55%43-12.24%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF5.65M2.51%1.00
Wasatch Ultra Growth5.59M2.28%1.06M
Vanguard Total Stock Mkt Idx Inv5.86M2.15%-129.35K
SPDR® S&P Biotech ETF3.73M1.75%-22.75K
Wasatch Micro Cap2.34M1.12%-3.31M
Vanguard Institutional Extnd Mkt Idx Tr2.36M0.87%-709.77K
Vanguard Strategic Small-Cap Equity Inv1.71M0.82%-
Vanguard Explorer Inv1.40M0.67%-
Schwab US Small-Cap ETF™1.07M0.44%-546.00
Fidelity Extended Market Index1.05M0.43%-2.73K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2023BIOGEN INC.-Sell$3.00M
Aug 29, 2022BIOGEN INC.-Sell$2.13M
Aug 30, 2022BIOGEN INC.-Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$2.13M

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

SGMO Ownership FAQ


Who Owns Sangamo Therapeutics?

Sangamo Therapeutics shareholders are primarily institutional investors at 19.94%, followed by 2.16% insiders and 77.90% retail investors. The average institutional ownership in Sangamo Therapeutics's industry, Biotech Stocks , is 306.59%, which Sangamo Therapeutics falls below.

Who owns the most shares of Sangamo Therapeutics?

Sangamo Therapeutics’s largest shareholders are Vanguard group (9.37M shares, 4.50%), Wasatch advisors lp (8.08M shares, 3.15%), and Blackrock (4.7M shares, 2.61%). Together, they hold 10.25% of Sangamo Therapeutics’s total shares outstanding.

Does Blackrock own Sangamo Therapeutics?

Yes, BlackRock owns 2.61% of Sangamo Therapeutics, totaling 4.7M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.69M$. In the last quarter, BlackRock decreased its holdings by -8.575M shares, a -64.58% change.

Who is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 1.26M Sangamo Therapeutics shares, valued at 682.13K$.

Who is the top mutual fund holder of Sangamo Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Sangamo Therapeutics shares, with 2.51% of its total shares outstanding invested in 5.65M Sangamo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools